Dean Gregory
Fortuna: 186 459 $ al 31/07/2026
Fortuna: 186 459 $ al 31/07/2026
Dean A. Gregory is currently Director at Illinois Biotechnology Industry Organization and Independent Director at Cerus Corp.
since 2024.
Formerly, Mr. Gregory was President-Medical Devices at Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) from 2012 to 2024, Senior Vice President-Sales & Operations at Fenwal, Inc. from 2010 to 2012, and VP-Business Development, Strategy & Marketing ROW at Baxter International, Inc. from 2002 to 2007.
Education includes an MBA from DePaul University and an undergraduate degree from the University of Illinois.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CERUS CORPORATION 0,04 % | 02/06/2026 | 86.725 ( 0,04 % ) | 186 459 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CERUS CORPORATION | Director/Miembro de la Junta | 01/07/2024 |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Director/Miembro de la Junta | 20/01/2010 |
| Empresas | Cargo | Fin |
|---|---|---|
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Corporate Officer/Principal | 01/03/2024 |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Director de Operaciones | 18/03/2010 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/02/2007 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Baxter International, Inc.
Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Cerus Corp.
Cerus Corp. Medical SpecialtiesHealth Technology Develops and commercializes the INTERCEPT Blood System for platelets and plasma | Health Technology |
DePaul University
DePaul University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fenwal, Inc.
Fenwal, Inc. BiotechnologyHealth Technology Manufactures blood collection and transfusion systems | Health Technology |
Illinois Biotechnology Industry Organization
Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Life science industry association | Commercial Services |
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.